Evidence map›Paper›PMID 38909055›Full record

ArticleNPJ vaccines2024

T cell independent antibody responses with class switch and memory using peptides anchored on liposomes.

Ásdís Hjálmsdóttir, Fabio Hasler, Ying Waeckerle-Men, Agathe Duda, María Pilar López-Deber, Maria Pihlgren, Marija Vukicevic, Thomas M Kündig, Pål Johansen

Abstract read
In one paragraph

Article in NPJ vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Antibody Responses to the ConservedPathogens (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ásdís HjálmsdóttirDepartment of Dermatology, University of Zurich, Zurich, Switzerland.
Fabio HaslerDepartment of Dermatology, University of Zurich, Zurich, Switzerland.
Ying Waeckerle-MenDepartment of Dermatology, University of Zurich, Zurich, Switzerland.
Agathe DudaDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.
María Pilar López-DeberAC Immune SA, EPFL Innovation Park EPFL, Lausanne, Switzerland.
Maria PihlgrenAC Immune SA, EPFL Innovation Park EPFL, Lausanne, Switzerland.
Marija VukicevicAC Immune SA, EPFL Innovation Park EPFL, Lausanne, Switzerland.
Thomas M KündigDepartment of Dermatology, University of Zurich, Zurich, Switzerland.
Pål JohansenDepartment of Dermatology, University of Zurich, Zurich, Switzerland. pal.johansen@usz.ch.ORCID http://orcid.org/0000-0002-5055-6299

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 31003A_149323Universität Zürich (University of Zurich) ForschungskreditUniversität Zürich (University of Zurich) Stiftung für wissenschaftliche Forschung
6 · The paper itself

Abstract

Vaccines generally require T lymphocytes for B-cell activation and immunoglobulin class switching in response to peptide or protein antigens. In the absence of T cells, limited IgG class switch takes place, germinal centers are short-lived, and the B cells lack memory. Here, immunization of mice with liposomes containing 15mer peptides and monophosphoryl lipid A (MPLA) as adjuvant, induced T-cell independent (TI) IgG class switch within three days, as well as germinal center formation. The antibody responses were long-lived, strictly dependent on Toll-like receptor 4 (TLR4) signaling, partly dependent on Bruton's tyrosine kinase (BTK) signal transmission, and independent of signaling through T-cell receptors, MHC class II and inflammasome. The antibody response showed characteristics of both TI type 1 and TI type 2. All IgG subclasses could be boosted months after primary immunization, and the biological function of the secreted antibodies was demonstrated in murine models of allergic anaphylaxis and of bacterial infection. Moreover, antibody responses after immunization with peptide- and MPLA-loaded liposomes could be triggered in neonatal mice and in mice receiving immune-suppressants. This study demonstrates T-cell independent endogenous B-cell memory and recall responses in vivo using a peptide antigen. The stimulation of these antibody responses required a correct and dense assembly and administration of peptide and adjuvant on the surface of liposomes. In the future, TI vaccines may prove beneficial in pathological conditions in which T-cell immunity is compromised through disease or medicines or when rapid, antibody-mediated immune protection is needed.

Identifiers

PMID38909055
PMCPMC11193769

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.